Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 218Triple Negative Breast Neoplasms 17Carcinoma, Intraductal, Noninfiltrating 15Breast Neoplasms, Male 15Inflammatory Breast Neoplasms 13Lung Neoplasms 11Prostatic Neoplasms 10Neoplasms 10Neoplasm Metastasis 10Breast Carcinoma In Situ 9Brain Neoplasms 9Carcinoma, Ductal, Breast 7Melanoma 6Carcinoma, Non-Small-Cell Lung 6Recurrence 5Rectal Neoplasms 4Radiation Injuries 4Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Lymphocytic, Chronic, B-Cell 4Hodgkin Disease 4Dendritic Cell Sarcoma, Interdigitating 4Carcinoma, Renal Cell 4Carcinoma, Lobular 4Burkitt Lymphoma 4Testicular Neoplasms 3

Interventions

palbociclib 1copanlisib 1Radiotherapy 1Radiation 1Fulvestrant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Estrogen Receptor Positive × Radiotherapy × Breast × Clear all
NCT03359954 2026-03-05

Radiation Therapy Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Breast Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
25 enrolled
Breast

Estrogen Receptor Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡